The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Female Fertility And Pregnancy Rapid Test Market By 2030?
The female fertility and pregnancy rapid test market has shown robust expansion in recent years. It is anticipated to increase from $1.48 billion in 2025 to $1.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. The historical growth trajectory can be ascribed to several factors, including heightened awareness of female reproductive health, a rise in the utilization of ovulation predictor kits, greater retail accessibility of rapid tests, the broadening of hospital-based diagnostic testing, and an escalating incidence of infertility diagnoses.
The female fertility and pregnancy rapid test market size is projected to experience robust expansion over the next few years. It is forecast to grow to $2.05 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period can be attributed to factors such as the increasing demand for early pregnancy detection, the rising adoption of digital health monitoring solutions, a growing focus on personalized fertility management, the expansion of telehealth-supported diagnostics, and the increasing penetration of e-commerce healthcare products. Significant trends expected during this period include the rising adoption of at-home rapid testing kits, an increasing demand for digital and app-connected test devices, the growing use of combo fertility and pregnancy tests, the expansion of online distribution channels, and an enhanced focus on user-friendly and accurate test designs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp
Which Growth Factors Are Strengthening The Female Fertility And Pregnancy Rapid Test Market Landscape?
The escalating occurrence of gynecological ailments is projected to stimulate the expansion of the female fertility and pregnancy rapid test market moving forward. Such ailments are health conditions affecting female reproductive organs, specifically the breasts and the abdominal and pelvic organs like the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. A female fertility and pregnancy rapid test aids in addressing gynecological disorders by enabling the prompt detection of hormonal imbalances or pregnancy-related concerns, thereby supporting timely diagnosis and effective management of reproductive health conditions. For instance, in May 2025, a report published by the National Library of Medicine, a US-based government organization, revealed that about 61.2% of women experienced at least one gynecological morbidity, with dysmenorrhea being the most common at 61.3%, followed by irregular menses at 36.1% and infertility also at 36.1%. Hence, the rising incidence of gynecological disorders is driving the growth of the female fertility and pregnancy rapid test market.
How Is Segment Classification Applied In The Female Fertility And Pregnancy Rapid Test Market?
The female fertility and pregnancy rapid test market covered in this report is segmented –
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2) By Device Type: Digital Devices, Line-indicator Devices
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel
Subsegments:
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests
What Trends Are Influencing The Female Fertility And Pregnancy Rapid Test Market?
Leading companies in the female fertility and pregnancy rapid test sector are concentrating on creating novel solutions, including saliva-based home pregnancy tests, to satisfy the growing need for non-invasive options. Such a test is a lateral-flow, point-of-care method designed to identify pregnancy indicators in oral fluid instead of urine. For example, in May 2024, Abingdon Health plc, a UK-based lateral flow CDMO, introduced the first Boots-branded saliva pregnancy self-test globally, accessible in Boots stores and online, thereby integrating this saliva technology into general retail. This product consists of a saliva collection component and a unique lateral-flow immunoassay, developed in collaboration with Salignostics and Crest Medical, intended to detect and signal the pregnancy biomarker in oral fluid; it operates as a quick, single-use self-test delivering results in minutes and is prepared for over-the-counter sales. It distinctively eliminates the need for urine collection from the testing process, enhancing comfort and hygiene, encourages consumer uptake via a recognizable “stick/cassette” design, and is purposed for regular home screening and early pregnancy confirmation, benefiting from Boots’ extended retail presence and customer confidence.
Who Are The Businesses Driving Activity In The Female Fertility And Pregnancy Rapid Test Market?
Major companies operating in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.
Access The Complete Female Fertility And Pregnancy Rapid Test Market Report:
Which Region Stands As The Largest Contributor To The Female Fertility And Pregnancy Rapid Test Market?
North America was the largest region in the female fertility and pregnancy rapid test market in 2025. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Female Fertility And Pregnancy Rapid Test Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Female Fertility And Pregnancy Rapid Test Market 2026, By The Business Research Company
Fertility Treatments Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Fertility Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
Male Fertility Market Report 2026
https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model